147 related articles for article (PubMed ID: 30882498)
21. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
22. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
[TBL] [Abstract][Full Text] [Related]
23. Low-dose CT for lung cancer screening: opportunities and challenges.
Shen H
Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
[TBL] [Abstract][Full Text] [Related]
24. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
25. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
26. Screening for lung cancer using low dose computed tomography.
Tammemagi MC; Lam S
BMJ; 2014 May; 348():g2253. PubMed ID: 24865600
[TBL] [Abstract][Full Text] [Related]
27. Screen-detected lung cancer: a retrospective analysis of CT appearance.
Dhopeshwarkar MR; Roberts HC; Paul NS; Dong Z; Tsao M; Menezes RJ
Acad Radiol; 2011 Oct; 18(10):1270-6. PubMed ID: 21813303
[TBL] [Abstract][Full Text] [Related]
28. What is overdiagnosis and why should we take it seriously in cancer screening?
Carter SM; Barratt A
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765855
[TBL] [Abstract][Full Text] [Related]
29. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary experiences with low-dose computed tomography for lung cancer screening in Hungary].
Moizs M; Bajzik G; Lelovics Z; Rakvács M; Strausz J; Repa I
Orv Hetil; 2014 Mar; 155(10):383-8. PubMed ID: 24583559
[TBL] [Abstract][Full Text] [Related]
31. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
32. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
33. Screening for lung cancer with low-dose CT.
Coche E
JBR-BTR; 2008; 91(1):1-5. PubMed ID: 18447122
[TBL] [Abstract][Full Text] [Related]
34. Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial.
Heleno B; Siersma V; Brodersen J
JAMA Intern Med; 2018 Oct; 178(10):1420-1422. PubMed ID: 30276415
[TBL] [Abstract][Full Text] [Related]
35. Lung Cancer Screening: Why, When, and How?
Fintelmann FJ; Gottumukkala RV; McDermott S; Gilman MD; Lennes IT; Shepard JO
Radiol Clin North Am; 2017 Nov; 55(6):1163-1181. PubMed ID: 28991558
[TBL] [Abstract][Full Text] [Related]
36. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
37. [CT-Screening for Lung Cancer - what is the Evidence?].
Watermann I; Reck M
Dtsch Med Wochenschr; 2018 Apr; 143(7):494-497. PubMed ID: 29614540
[TBL] [Abstract][Full Text] [Related]
38. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
39. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features.
Pajares MJ; Zudaire I; Lozano MD; Agorreta J; Bastarrika G; Torre W; Remírez A; Pio R; Zulueta JJ; Montuenga LM
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):373-80. PubMed ID: 16492931
[TBL] [Abstract][Full Text] [Related]
40. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
